Insider Transactions in Q3 2025 at Keros Therapeutics, Inc. (KROS)

KROS Quotes by TradingView

Insider Transaction List (Q3 2025)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Sep 03 2025
Jasbir Seehra CHIEF EXECUTIVE OFFICER
BUY
Grant, award, or other acquisition
Direct
90,500 +18.73%
-

Track Institutional and Insider Activities on KROS

Follow Keros Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KROS shares.

Notify only if

Insider Trading

Get notified when an Keros Therapeutics, Inc. insider buys or sells KROS shares.

Notify only if

News

Receive news related to Keros Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KROS